Fair Value Measurements - Narrative (Details)	3 Months Ended
	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Jul. 02, 2024 USD ($)
Debt Instrument [Line Items]
Asset impairment charges	$ 0
Contingent consideration obligations	294,300,000	$ 291,200,000
Contingent consideration obligations	$ 228,100,000
Human Immunology Biosciences
Debt Instrument [Line Items]
Contingent consideration obligations			$ 279,300,000
Contingent consideration obligations			$ 205,800,000
Human Immunology Biosciences | Measurement Input, Probability Rate
Debt Instrument [Line Items]
Discount rate	0.700		0.670